“The objective is to make India self-reliant in production of 53 critical (active pharmaceutical ingredients) APIs or Key Starting Materials (KSMs), and in production of medical devices, for which India is crucially dependent upon imports,” Sadananda Gowda, the federal minister for chemicals and fertilisers, tweeted on Monday.
